Halozyme Therapeutics | HALO - Выручка от реализации

Биржевая цена
63.14
Изменение за день
-0.13 -0.21%
Ежемесячно
-10.62%
Ежегодный
-3.10%
Q1 прогноз
61.74




Продажи Изменить Дата
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amarin USD 49.22M 451K 2025-12
Amgen USD 9.9B 340M 2025-12
Baxter International USD 2.97B 130M 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cytokinetics USD 17.76M 15.83M 2025-12
DBV Technologies USD 2.77M 1.31M 2025-09
Eli Lilly USD 19.3B 1.7B 2025-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
Intrexon USD 717K 511K 2024-06
Ionis Pharmaceuticals USD 203M 46M 2025-12
MannKind USD 111.96M 29.83M 2025-12
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 24.12M 635K 2024-09
Pfizer USD 17.58B 880M 2025-12
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
United Therapeutics USD 790.2M 9.3M 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12